Skip to content

Mind Body Intervention for Chronic Upper Extremity Pain (Repetitive Stress Injury)

RecruitingNot applicableNCT06903962
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The goal of this nonrandomized pilot study is to test a mind-body interventional approach for the treatment of chronic upper extremity pain or repetitive stress injury of the upper extremity (wrist/shoulder/elbow). 1. To determine if a mind-body intervention improves upper extremity functional capacity (ie., Disability of Arm Shoulder Hand - DASH) among people with chronic wrist, elbow, and shoulder pain 2. To determine if a mind-body intervention decreases pain intensity, pain-related anxiety, and overall somatic complaints in our trial participants. 3. To tailor the intervention and the outcomes assessment procedures for conducting a trial in a population with upper extremity pain.

Study details

Official title
Mind Body Intervention for Chronic Upper Extremity Pain (Repetitive Stress Injury)
Conditions
Interventions
  • Behavioral: Mind-Body Intervention
Sponsor
Beth Israel Deaconess Medical Center
Start date
2025-03-28
Primary completion
2026-12-31
Sex
All
Age range
from 18 Years to 60 Years
Results posted
No results posted in this snapshot
Countries
United States
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Adult (≥ 18 years of age) 2. A disability score ≥ 40 as per the QuickDASH survey 3. Presence of pain and perceived disability for a minimum of 3 months 4. Willing to engage in a Mind-Body intervention 5. Positive visualization test (onset of pain when patients visualize themselves performing tasks that generally bring on pain) Exclusion Criteria: 1. Clear organic diagnosis of pain (e.g., cancer, infection, etc…) not inclusive of non-specific findings on imaging studies (e.g., mild arthritis) 2. Age greater than 60 years (due to an increased risk of there being an organic/physical cause for their pain and confounding results) 3. Diagnosis of cognitive impairment or dementia 4. Active addiction disorder, e.g. cocaine or IV heroin use, that would interfere with study participation 5. Major psychiatric comorbidity (e.g., schizophrenia). Anxiety and mild-moderate depression are not considered in this category

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06903962